NCT03050489

Brief Summary

Assessment of myocardial ischemic-reperfusion injury during off- and on- pump CABG.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
336

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2015

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

February 6, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 13, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

January 13, 2023

Completed
Last Updated

January 13, 2023

Status Verified

April 1, 2022

Enrollment Period

3.7 years

First QC Date

February 6, 2017

Results QC Date

June 18, 2021

Last Update Submit

April 11, 2022

Conditions

Keywords

CABGOff-Pump CABGOn-Pump CABGischemic-reperfusion injury during CABGcomparison of On- and Off- Pump CABGIschemic Heart DiseaseMyocardial ischemia-reperfusion and myeloperoxidaseMyocardial ischemia-reperfusion biomarkers

Outcome Measures

Primary Outcomes (1)

  • Myeloperoxidase

    Level of serum myeloperoxidase just after sternal closure

    Level of serum myeloperoxidase just after sternal closure

Secondary Outcomes (11)

  • Low Cardiac Output Syndrome

    Up to 30 days after surgical procedure

  • Length of Stay in Intensive Care Unit

    During 30 days after procedure or more

  • Length of Stay in Hospital

    During 30 days after procedure or more

  • Cumulative Dose of Inotrope

    Up to 30 days after procedure

  • Days of Administration of Inotrope

    During 30 days after procedure or more

  • +6 more secondary outcomes

Other Outcomes (2)

  • Death

    During 30 days after procedure

  • Stroke

    During 30 days after procedure

Study Arms (3)

On-Pump CABG

Patients with coronary artery bypass graft (CABG) surgery performed with cardiopulmonary bypass.

Procedure: On-Pump CABG.

Off-Pump CABG

Patients with coronary artery bypass graft (CABG) surgery performed without cardiopulmonary bypass.

Procedure: Off-Pump CABG.

BH-CABG MSC.

Patients with coronary artery bypass graft (CABG) surgery performed on beating heart with mechanical support of circulation.

Procedure: BH-CABG MSC.

Interventions

On-Pump CABG.PROCEDURE

Standard On-Pump CABG.

On-Pump CABG

Standard Off-Pump CABG.

Off-Pump CABG
BH-CABG MSC.PROCEDURE

Patients with coronary artery bypass graft (CABG) surgery performed on beating heart with mechanical support of circulation

BH-CABG MSC.

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with ischemic heart disease.

You may qualify if:

  • ischemic heart disease

You may not qualify if:

  • valve disease
  • diabetes millitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Pavlov State Medical University of St. Petersburg

Saint Petersburg, 197089, Russia

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum from central vein.

MeSH Terms

Conditions

Myocardial IschemiaCoronary Artery Disease

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular DiseasesCoronary DiseaseArteriosclerosisArterial Occlusive Diseases

Limitations and Caveats

Unequal amount of participants in arms (few patients were enrolled in off-pump arm).

Results Point of Contact

Title
Nikolay Bunenkov
Organization
First State Pavlov Medical University

Study Officials

  • Alexander S Nemkov, PhD, MD

    PSPbGMU

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2017

First Posted

February 13, 2017

Study Start

September 15, 2015

Primary Completion

May 31, 2019

Study Completion

May 31, 2019

Last Updated

January 13, 2023

Results First Posted

January 13, 2023

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations